Once-Monthly MS Injection Approved in US - Wall Street Journal

Wall Street Journal

Once-Monthly MS Injection Approved in US Wall Street Journal U.S. regulators approved the once-monthly, self-administered injection to treat multiple sclerosis made by Biogen Inc. BIIB 0.28 % and AbbVie Inc., ABBV 1.31 % but with a warning about the drug causing possible liver damage. Biogen and AbbVie are ... Biogen and AbbVie Receive FDA Approval of Once-Monthly ZINBRYTA™ (daclizumab) for Multiple SclerosisPR Newswire (press release) FDA Approves Daclizumab (Zinbryta ) for Multiple SclerosisMedscape FDA approves Zinbryta to treat multiple sclerosisFDA.gov Reuters -Nasdaq -Seeking Alpha -The Ledger Gazette all 13 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNGMg8F585SmQM6j5lfsjQpUMaWGqw&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779120704531&ei=LAlJV_jyIMa_3gHYhKfQAQ&url=http://www.wsj.com/articles/once-monthly-ms-injection-approved-in-u-s-1464403276
via IFTTT